{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:23:42Z","timestamp":1774715022522,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011893","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000}}],"reference-count":61,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011893.pub2","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T20:10:57Z","timestamp":1520021457000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants"],"prefix":"10.1002","volume":"2018","author":[{"given":"Siree","family":"Kaempfen","sequence":"first","affiliation":[{"name":"University of Basel Children's Hospital (UKBB); Department of Neonatology; Basel Basel Switzerland CH-4031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland P","family":"Neumann","sequence":"additional","affiliation":[{"name":"University of Basel Children's Hospital (UKBB); Department of Neonatology; Basel Basel Switzerland CH-4031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Jost","sequence":"additional","affiliation":[{"name":"University of Basel Children's Hospital (UKBB); Department of Neonatology; Basel Basel Switzerland CH-4031"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven M","family":"Schulzke","sequence":"additional","affiliation":[{"name":"University of Basel Children's Hospital (UKBB); Department of Neonatology; Basel Basel Switzerland CH-4031"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD011893.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD011893.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/02713683.2016.1158272","article-title":"The efficacy of propranolol in retinopathy of prematurity and its correlation with the platelet mass index","volume":"42","author":"Korkmaz","year":"2017","journal-title":"Current Eye Research"},{"issue":"5","key":"10.1002\/14651858.CD011893.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"F389","DOI":"10.1136\/archdischild-2016-311548","article-title":"Prophylactic propranolol for prevention of ROP and visual outcome at 1\u2005year (PreROP trial)","volume":"102","author":"Sanghvi","year":"2017","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"5","key":"10.1002\/14651858.CD011893.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/jpm-2015-0357","article-title":"Oral propranolol in early stages of retinopathy of prematurity","volume":"44","author":"Bancalari","year":"2016","journal-title":"Journal of Perinatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/pr.2016.230","article-title":"Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial","volume":"81","author":"Filippi","year":"2017","journal-title":"Pediatric Research"},{"issue":"7","key":"10.1002\/14651858.CD011893.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/archdischild-2013-303951","article-title":"Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study","volume":"98","author":"Makhoul","year":"2013","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0007|cit7","unstructured":"NCT01660620 Topical betaxolol for the prevention of retinopathy of prematurity clinicaltrials.gov\/show\/NCT01660620"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0008|cit8","unstructured":"NCT03038295 A prospective cohort study for propranolol treatment in retinopathy of prematurity clinicaltrials.gov\/show\/NCT03038295"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0009|cit9","unstructured":"NCT03083431 Propranolol for prevention of threshold retinopathy of prematurity (ROPROP) clinicaltrials.gov\/show\/NCT03083431"},{"issue":"6","key":"10.1002\/14651858.CD011893.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaad.2014.01.905","article-title":"Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study","volume":"70","author":"\u00c1barz\u00faa-Araya","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2-3","key":"10.1002\/14651858.CD011893.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.mvr.2007.04.011","article-title":"Retinal and choroidal microangiopathies: therapeutic opportunities","volume":"74","author":"Afzal","year":"2007","journal-title":"Microvascular Research"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001693","article-title":"Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants","author":"Andersen","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011893.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.38.7.397","article-title":"Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia","volume":"38","author":"Asthon","year":"1954","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0014|cit14","volume-title":"Bayley scales of infant and toddler development","author":"Bayley","year":"2006"},{"issue":"1","key":"10.1002\/14651858.CD011893.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","article-title":"Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging","volume":"187","author":"Bell","year":"1978","journal-title":"Annals of Surgery"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011893.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"Blencowe","year":"2013","journal-title":"Pediatric Research"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1525-1470.2009.01081.x","article-title":"Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol","volume":"27","author":"Bonifazi","year":"2010","journal-title":"Pediatric Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011893.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000381659","article-title":"Oral propranolol: a new treatment for infants with retinopathy of prematurity?","volume":"108","author":"B\u00fchrer","year":"2015","journal-title":"Neonatology"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.preteyeres.2014.06.001","article-title":"The \u03b2-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases","volume":"42","author":"Casini","year":"2014","journal-title":"Progress in Retinal and Eye Research"},{"issue":"1","key":"10.1002\/14651858.CD011893.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"2-20","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro","year":"2014","journal-title":"Acta Ophthalmologica"},{"issue":"1","key":"10.1002\/14651858.CD011893.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1525-1470.2011.01664.x","article-title":"Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study","volume":"29","author":"Chakkittakandiyil","year":"2012","journal-title":"Pediatric Dermatology"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Chen J Joyal JS Hatton CJ Juan AM Pei DT Hurst CG Propranolol inhibition of \u03b2-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy Investigative Ophthalmology & Visual Science 2012 2968 77 10.1167\/iovs.12-9691","DOI":"10.1167\/iovs.12-9691"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","article-title":"Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice","volume":"111","author":"Dal Monte","year":"2013","journal-title":"Experimental Eye Research"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","article-title":"Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants","volume":"65","author":"Graaf","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011893.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD011893.pub2-BIB0026|cit26","first-page":"450","article-title":"Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants","volume":"52","author":"Erbay","year":"2010","journal-title":"Turkish Journal of Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD011893.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1684-94","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Ferrara N Davis-Smyth T The biology of vascular endothelial growth factor Endocrine Reviews 1997 4 25 10.1210\/edrv.18.1.0287","DOI":"10.1210\/edrv.18.1.0287"},{"issue":"3","key":"10.1002\/14651858.CD011893.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/med.21336","article-title":"Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the \u03b2-adrenergic system","volume":"35","author":"Filippi","year":"2014","journal-title":"Medicinal Research Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011893.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1185\/03007990903533681","article-title":"Effects of beta-blockers on glucose and lipid metabolism","volume":"26","author":"Fonseca","year":"2010","journal-title":"Current Medical Research and Opinion"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD011893.pub2-BIB0031|cit31","first-page":"II21","article-title":"Beta-adrenergic receptor blockers. Adverse effects and drug interactions","volume":"11","author":"Frishman","year":"1988","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD011893.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/ajd.12079","article-title":"Dangers of propranolol in preterm infants","volume":"54","author":"Frost","year":"2013","journal-title":"Australasian Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Human Development"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0034|cit34","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2015"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0035|cit35","volume-title":"The abilities of babies: a study in mental measurement","author":"Griffiths","year":"1954"},{"issue":"9902","key":"10.1002\/14651858.CD011893.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0037|cit37","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8","key":"10.1002\/14651858.CD011893.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1651-2227.2011.02330.x","article-title":"On the use of antiangiogenetic medications for retinopathy of prematurity","volume":"100","author":"H\u00e5rd","year":"2011","journal-title":"Acta Paediatrica"},{"issue":"7","key":"10.1002\/14651858.CD011893.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"991-9","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Archives of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD011893.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","article-title":"Bronchopulmonary dysplasia","volume":"163","author":"Jobe","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011893.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jemermed.2003.11.015","article-title":"Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers","volume":"26","author":"Love","year":"2004","journal-title":"Journal of Emergency Medicine"},{"issue":"24","key":"10.1002\/14651858.CD011893.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD011893.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"L\u00f6fqvist C Andersson E Sigurdsson J Engstr\u00f6m E H\u00e0rd AL Niklasson A Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity Archives of Ophthalomolgy 2006 1711 8 10.1001\/archopht.124.12.1711","DOI":"10.1001\/archopht.124.12.1711"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2133.2009.09597.x","article-title":"Propranolol for complicated infantile haemangiomas: a case series of 30 infants","volume":"162","author":"Manunza","year":"2010","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD011893.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1471-4159.2011.07530.x","article-title":"Antiangiogenic effects of \u03b22-adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy","volume":"119","author":"Martini","year":"2011","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1002\/14651858.CD011893.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"329-38 Erratum","DOI":"10.1159\/000260136","article-title":"Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003","volume":"97","author":"Mercier","year":"2010","journal-title":"Neonatology"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3980\/j.issn.2222-3959.2013.02.23","article-title":"Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options","volume":"6","author":"Mutlu","year":"2013","journal-title":"International Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD011893.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/pr.2014.108","article-title":"Pharmacokinetics and local safety profile of propranolol eye drops in rabbits","volume":"76","author":"Padrini","year":"2014","journal-title":"Pediatric Research"},{"issue":"4","key":"10.1002\/14651858.CD011893.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile","year":"1978","journal-title":"Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD011893.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1542\/peds.2010-0077","article-title":"Hyperkalemia complicating propranolol treatment of an infantile hemangioma","volume":"126","author":"Pavlakovic","year":"2010","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Praveen V Vidavalur R Rosenkrantz TS Hussain N Infantile hemangiomas and retinopathy of prematurity: possible association Pediatrics 2009 e484 9 10.1542\/peds.2007-0803","DOI":"10.1542\/peds.2007-0803"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0053|cit53","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"1","key":"10.1002\/14651858.CD011893.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1002\/14651858.CD011893.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009734.pub2","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","author":"Sankar","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011893.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe infantile hemangiomas: follow-up report","volume":"124","author":"Sans","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD011893.pub2-BIB0057|cit57","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"12","key":"10.1002\/14651858.CD011893.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011893.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1084-2756(03)00119-2","article-title":"Pathogenesis of retinopathy of prematurity","volume":"8","author":"Smith","year":"2003","journal-title":"Seminars in Neonatology"},{"issue":"6","key":"10.1002\/14651858.CD011893.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/14767050701398413","article-title":"Mid- and long-term outcome of extremely low birth weight (ELBW) infants: an analysis of prognostic factors","volume":"20","author":"Valcamonico","year":"2007","journal-title":"Journal of Maternal-fetal & Neonatal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011893.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.jp.7210963","article-title":"Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia","volume":"23","author":"Walsh","year":"2003","journal-title":"Journal of Perinatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011893.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T07:01:59Z","timestamp":1644476519000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011893.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neonatal Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011893.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]}}}